nach oben

Erschienen in:

18.11.2019 | Review Article

Treatment Rate for Major Depressive Disorder in China: a Meta-Analysis of Epidemiological Studies

verfasst von: Han Qi, Qian-Qian Zong, Grace K. I. Lok, Wen-Wang Rao, Feng-Rong An, Gabor S. Ungvari, Lloyd Balbuena, Qing-E Zhang, Yu-Tao Xiang

Erschienen in: Psychiatric Quarterly | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Major depressive disorder (MDD) is a common psychiatric disorder in China, but its reported treatment rate varies largely across different studies. The objective of this meta-analysis was to determine the pooled treatment rate for people with MDD in China and its associated factors. Both English (PubMed, Cochrane Library, PsycINFO, Web of Science) and Chinese (Chinese National Knowledge Infrastructure, WanFang and SinoMed) databases were searched from their commencement date to November 13, 2018. Epidemiological studies that reported the treatment rate of MDD were included and synthesized using a random effects model. Fifteen studies covering 609,054 participants were included. The pooled treatment rate for MDD in China was 19.5% (95% CI: 10.7%–28.4%). Among the 15 studies, 9 reported the number of patients who received treatments in psychiatric hospitals with a pooled treatment rate of 5.2% (95% CI: 2.8%–7.5%). Meta-regression found that study quality (β = 0.131, P = 0.028) and male gender (β = 0.006, P = 0.039) were significantly associated with a higher treatment rate for MDD. In China, the treatment rate for MDD, particularly in psychiatric hospitals, was low. Effective public education and increasing access to mental health services will probably increase the number of people seeking and receiving treatment.

Nur mit Berechtigung zugänglich

Ferrari A, Somerville A, Baxter A, et al. Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature. Psychol Med. 2013;43(3):471–81.PubMed

Steel Z, Marnane C, Iranpour C, et al. The global prevalence of common mental disorders: a systematic review and meta-analysis 1980-2013. Int J Epidemiol. 2014;43(2):476–93.PubMedPubMedCentral

Kleinman A. Culture and depression. N Engl J Med. 2004;351(10):951–3.PubMed

Compton WM, Conway KP, Stinson FS, et al. Changes in the prevalence of major depression and comorbid substance use disorders in the United States between 1991-1992 and 2001-2002. Am J Psychiatry. 2006;163(12):2141–7.PubMed

Zhong XM, Dong M, Wang F, et al. Physical comorbidities in older adults receiving antidepressants in Asia. Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society. 2018;18(5):351–6.

Phillips MR, Liu H, Zhang Y. Suicide and social change in China. Cult Med Psychiatry. 1999;23(1):25–50.PubMed

Lee S, Tsang A, Zhang MY, et al. Lifetime prevalence and inter-cohort variation in DSM-IV disorders in metropolitan China. Psychol Med. 2007;37(1):61–71.PubMed

Gu L, Xie J, Long J, et al. Epidemiology of major depressive disorder in mainland China: a systematic review. PLoS One. 2013;8(6):e65356.PubMedPubMedCentral

Fröjd SA, Nissinen ES, Pelkonen MU, et al. Depression and school performance in middle adolescent boys and girls. J Adolesc. 2008;31(4):485–98.PubMed

10.

Buysse DJ, Angst J, Gamma A, et al. Prevalence, course, and comorbidity of insomnia and depression in young adults. Sleep. 2008;31(4):473–80.PubMedPubMedCentral

11.

Lynch FL, Clarke GN. Estimating the economic burden of depression in children and adolescents. Am J Prev Med. 2006;31(6):143–51.

12.

Penninx BW. Depression and cardiovascular disease: Epidemiological evidence on their linking mechanisms. Neurosci Biobehav Rev. 2017;74(Pt B):277–86.PubMed

13.

Kendler KS, Gardner CO, Fiske A, et al. Major depression and coronary artery disease in the Swedish twin registry: phenotypic, genetic, and environmental sources of comorbidity. Arch Gen Psychiatry. 2009;66(8):857–63.PubMedPubMedCentral

14.

Cassano GB, Rucci P, Frank E, et al. The mood spectrum in unipolar and bipolar disorder: arguments for a unitary approach. Am J Psychiatry. 2004;161(7):1264–9.PubMed

15.

Karyotaki E, Smit Y, Holdt Henningsen K, et al. Combining pharmacotherapy and psychotherapy or monotherapy for major depression? A meta-analysis on the long-term effects. J Affect Disord. 2016;194:144–52.PubMed

16.

Bijl RV, de Graaf R, Hiripi E, et al. The prevalence of treated and untreated mental disorders in five countries. Health affairs (Project Hope). 2003;22(3):122–33.

17.

Demyttenaere K, Bruffaerts R, Posada-Villa J, et al. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization world mental health surveys. JAMA. 2004;291(21):2581–90.PubMed

18.

Olfson M, Blanco C, Marcus SC. Treatment of adult depression in the United States. JAMA Intern Med. 2016;176(10):1482–91.PubMed

19.

Yu C, Lyu J, Chen Y, et al. Epidemiology of major depressive episodes among Chinese adults aged 30–79 years: data from the China Kadoorie Biobank (in Chinese). ZHLXBXZZ. 2015;36(1):52–6.

20.

Liu XJ, Zhou Y, Dong L, et al. A survey of major depression among elderly population in Wuhan (in Chinese). Chin Ment Health J. 2017;11:851–6.

21.

Chin WY, Chan KT, Lam CL, et al. Help-seeking intentions and subsequent 12-month mental health service use in Chinese primary care patients with depressive symptoms. BMJ Open. 2015;5(1):e006730.PubMedCentralPubMed

22.

Liang D, Mays VM, Hwang WC. Integrated mental health services in China: challenges and planning for the future. Health Policy Plan. 2018;33(1):107–22.PubMed

23.

Desai HD, Jann MW. Major depression in women: a review of the literature. J Am Pharm Assoc (Wash). 2000;40(4):525–37.

24.

Chen Y, Bennett D, Clarke R, et al. Patterns and correlates of major depression in Chinese adults: a cross-sectional study of 0.5 million men and women. Psychol Med. 2017;47(5):958–70.PubMed

25.

Shidhaye R, Mendenhall E, Sumathipala K, et al. Association of somatoform disorders with anxiety and depression in women in low and middle income countries: a systematic review. Int Rev Psychiatry. 2013;25(1):65–76.PubMedPubMedCentral

26.

Guo J, Liu C, Wang X, et al. Relationships between depression, pain and sleep quality with doctor visits among community-based adults in north-West China. Public Health. 2017;147:30–8.PubMed

27.

Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Open Med. 2009;3(3):e123–30.PubMedPubMedCentral

28.

Boyle MH. Guidelines for evaluating prevalence studies. Evid Based Ment Health. 1998;1(2):37–9.

29.

Pringsheim T, Jette N, Frolkis A, et al. The prevalence of Parkinson's disease: a systematic review and meta-analysis. Mov Disord. 2014;29(13):1583–90.PubMed

30.

Loney PL, Chambers LW, Bennett KJ, et al. Critical appraisal of the health research literature: prevalence or incidence of a health problem. Chronic Dis Can. 1998;19(4):170–6.PubMed

31.

Ibrahim AK, Kelly SJ, Adams CE, et al. A systematic review of studies of depression prevalence in university students. J Psychiatr Res. 2013;47(3):391–400.PubMed

32.

Parker G, Beresford B, Clarke S, et al. Technical report for SCIE research review on the prevalence and incidence of parental mental health problems and the detection, screening and reporting of parental mental health problems. University of York: Social Policy Research Unit; 2008.

33.

Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.PubMedPubMedCentral

34.

Rotenstein LS, Ramos MA, Torre M, et al. Prevalence of depression, depressive symptoms, and suicidal ideation among medical students: a systematic review and meta-analysis. Jama. 2016;316(21):2214–36.PubMedPubMedCentral

35.

Zhang ZZ. Evolution and Evaluation of the Chinese Economic Regions Division(in Chinese). Journal of Shanxi University of Finance and Economics(Higher Education Edition). 2010;13(02):89–92.

36.

Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.PubMedPubMedCentral

37.

Jie R, Wang GP, Ding ZJ, et al. Investigation of major depression disorder in the people over 60 years old in Tianshui (in Chinese). Int J Geriatr. 2017;38(6):259–62.

38.

Ou QM, Deng SL, Zhai WG. Epidemiological investigation and efficacy analysis of the influencing factors of depression in Huizhou, Guangdong province in 2015 (in Chinese). Modern Diagnosis and Treatment. 2016;11:2066–8.

39.

Gupta S, Goren A, Dong P, et al. Prevalence, awareness, and burden of major depressive disorder in urban China. Expert Rev Pharmacoecon Outcomes Res. 2016;16(3):393–407.PubMed

40.

Peng J, Sun D, Song Y. Investigation on the treatment rates of depression in Mudanjiang city. China Journal of Modern Medicine (in Chinese). 2013;23(5):108–10.

41.

Ye MJ, Zhong SZ, Lin CY, et al. Prevalence, influencing factors and help-seeking style of depression among elderly population in Wenzhou area (in Chinese). Chin J Public Health. 2013;29(01):8–11.

42.

Sun XR, Qu ZF, Jiang Q, et al. Investigation the epidemiology of senile depression in community of Pudong New Area, Shanghai (in Chinese). Medical Journal of Chinese People's Health. 2011;23(9):1078–1080,1119.

43.

Duan WD, Liu TB, Hu CY, et al. Cross-sectional survey of depressive disorder in Shenzhen City in 2005 (in Chinese). Chinese Journal of Psychiatry. 2010;43(4):211–6.

44.

Gui LH, Epidemiology Study on Depression among Rural Residents in Liuyang (in Chinese). 2010, Central South University.

45.

Ma X, Xiang YT, Cai ZJ, et al. Prevalence and socio-demographic correlates of major depressive episode in rural and urban areas of Beijing. China Journal of Affective Disorders. 2009;115(3):323–30.PubMed

46.

Lee S, Tsang A, Huang YQ, et al. The epidemiology of depression in metropolitan China. Psychol Med. 2009;39(5):735–47.PubMed

47.

Ma X, Xiang YT, Li SR, et al. Prevalence and sociodemographic correlates of depression in an elderly population living with family members in Beijing, China. Psychol Med. 2008;38(12):1723–30.PubMed

48.

Cui LJ, Su KQ, Jiang QP, et al. The prevalence of major depression disorders in Hebei Province from 2004 to 2005 (in Chinese). Chinese Journal of Psychiatry. 2007;40(03):140–3.

49.

Phillips MR, Zhang J, Shi Q, et al. Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001–05: an epidemiological survey. Lancet (London, England). 2009;373(9680):2041–53.

50.

Wang PS, Aguilar-Gaxiola S, Alonso J, et al. Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys. Lancet (London, England). 2007;370(9590):841–50.

51.

Xiang YT, Ng CH, Yu X, et al. Rethinking progress and challenges of mental health care in China. World Psychiatry. 2018;17(2):231–2.PubMedPubMedCentral

52.

Xiang YT, Yu X, Ungvari GS, et al. China's National Mental Health law: a 26-year work in progress. Lancet. 2012;379(9818):780–2.PubMed

53.

Phillips MR. Can China's new mental health law substantially reduce the burden of illness attributable to mental disorders? Lancet (London, England). 2013;381(9882):1964–6.

54.

Tsang HW, Angell B, Corrigan PW, et al. A cross-cultural study of employers' concerns about hiring people with psychotic disorder: implications for recovery. Soc Psychiatry Psychiatr Epidemiol. 2007;42(9):723–33.PubMed

55.

Cole MG, Yaffe MJ. Pathway to psychiatric care of the elderly with depression. Int J Geriatr Psychiatry. 1996;11(2):157–61.

56.

Lee S, Tsang A, Kwok K. Twelve-month prevalence, correlates, and treatment preference of adults with DSM-IV major depressive episode in Hong Kong. J Affect Disord. 2007;98(1–2):129–36.PubMed

57.

Kessler RC, Birnbaum HG, Shahly V, et al. Age differences in the prevalence and co-morbidity of DSM-IV major depressive episodes: results from the WHO world mental health survey initiative. Depress Anxiety. 2010;27(4):351–64.PubMedCentralPubMed

58.

Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). Jama. 2003;289(23):3095–105.PubMed

59.

Pedrelli P, Borsari B, Lipson SK, et al. Gender differences in the relationships among major depressive disorder, heavy alcohol use, and mental health treatment engagement among college students. J Stud Alcohol Drugs. 2016;77(4):620–8.PubMedPubMedCentral

60.

Chen F. A modern interpretation of "the domestic wife and social husband". Journal of Yuxi Teachers College. 2003;12:18–21.

61.

Winsper C, Ganapathy R, Marwaha S, et al. A systematic review and meta-regression analysis of aggression during the first episode of psychosis. Acta Psychiatr Scand. 2013;128(6):413–21.PubMed

62.

Long J, Huang G, Liang W, et al. The prevalence of schizophrenia in mainland China: evidence from epidemiological surveys. Acta Psychiatr Scand. 2014;130(4):244–56.PubMed

63.

Li Y, Cao XL, Zhong BL, et al. Smoking in male patients with schizophrenia in China: a meta-analysis. Drug Alcohol Depend. 2016;162:146–53.PubMed

64.

Mata DA, Ramos MA, Bansal N, et al. Prevalence of depression and depressive symptoms among resident physicians: a systematic review and meta-analysis. JAMA. 2015;314(22):2373–83.PubMedPubMedCentral

Titel: Treatment Rate for Major Depressive Disorder in China: a Meta-Analysis of Epidemiological Studies
verfasst von: Han Qi
Qian-Qian Zong
Grace K. I. Lok
Wen-Wang Rao
Feng-Rong An
Gabor S. Ungvari
Lloyd Balbuena
Qing-E Zhang
Yu-Tao Xiang
Publikationsdatum: 18.11.2019
Verlag: Springer US
Erschienen in: Psychiatric Quarterly / Ausgabe 4/2019
Print ISSN: 0033-2720
Elektronische ISSN: 1573-6709
DOI: https://doi.org/10.1007/s11126-019-09666-9

Neu im Fachgebiet Psychiatrie

12.04.2024 | Vitiligo | Nachrichten

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Treatment Rate for Major Depressive Disorder in China: a Meta-Analysis of Epidemiological Studies

Abstract

Neu im Fachgebiet Psychiatrie

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Impostor-Syndrom häufig bei Hyperhidrose zu finden

KI sagt Suizidrisiko vorher

Perinatale PTBS: Signifikanter Anstieg der Diagnoserate

Update Psychiatrie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2019

The Prevalence of Suicide Attempts and Independent Demographic and Clinical Correlates among Chronic Schizophrenia Patients in Agricultural Areas of China

Does Change over Time in Delusional Beliefs as Measured with PDI Predict Change over Time in Belief Flexibility Measured with MADS?

Development and Factorial Validation of the Inventory of Deliberate Self-Harm Behaviours for Portuguese Adolescents

Perfectionism Moderates the Relationship between Thwarted Belongingness and Perceived Burdensomeness and Suicide Ideation in Adolescents

A Further Test of the Impact of Online Gaming on Psychological Wellbeing and the Role of Play Motivations and Problematic Use

Enhancing Access to Psychiatric Care for Posttraumatic Stress Disorder in Veterans with Mild Traumatic Brain Injury through Integrated Services

Neu im Fachgebiet Psychiatrie

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Impostor-Syndrom häufig bei Hyperhidrose zu finden

KI sagt Suizidrisiko vorher

Perinatale PTBS: Signifikanter Anstieg der Diagnoserate

Update Psychiatrie